Deep search
Rewards
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Novo Nordisk faces US Senate committee
Senate panel questions Novo Nordisk CEO over decision to discontinue this popular insulin
Novo Nordisk CEO explains decision to discontinue the long-acting insulin Levemir. He blamed pharmacy managers and health insurers.
Senators press Novo Nordisk CEO on why Ozempic and Wegovy cost less abroad
Weight-loss drugs sell in Europe for a fraction of what they cost in the United States, a pattern that is typical for brand-name prescriptions.
Novo Nordisk CEO To Face Senate Scrutiny Over High Ozempic And Wegovy Prices, Hearing Scheduled On Tuesday
Novo Nordisk CEO Lars Fruergaard Jørgensen faces a Senate hearing led by Bernie Sanders over the high cost of Ozempic and Wegovy, as U.S. lawmakers push for drug price reductions.
2d
Novo Nordisk CEO grilled over steep weight loss drug costs
Novo Nordisk CEO Lars Fruergaard Jørgensen testified before the Senate Health, Education, Labor and Pension committee on ...
2d
US Congress calls on Novo Nordisk to lower drug prices
The boss of the Danish pharmaceutical giant behind the blockbuster diabetes and weight-loss drugs Ozempic and Wegovy promised ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Trending now
Promotes watch collection
Killer gets life sentence
World's oldest cheese found
Fake Biden robocalls fine
Ending password-sharing
Producing doc on Diddy
50/50 ball ownership suit
Boxes to distribute Narcan
Urgent safety alert for 737s
US sanctions crypto network
Targeted Black residents?
Stadiums to serve as shelters
OK's new schizophrenia drug
Chinese submarine sank
More executives leave
On Secret Service failures
WI duplicate ballot flap
NIH finds misconduct
NC board removes 747K
Arrives in Luxembourg
Kotb leaving 'Today'
Capital goods orders up
Rose announces retirement
US economy grew
Military recruiting rebounds
To withdraw sickle cell drug
Settles defamation lawsuit
RU hits Ukraine's power grid
US suicides steady, high
Feedback